- Home
- CNTY vs GANX Comparison
CNTY vs GANX Comparison
Compare CNTY & GANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTY
- GANX
- Stock Information
- Founded
- CNTY 1992
- GANX 2017
- Country
- CNTY United States
- GANX United States
- Employees
- CNTY N/A
- GANX N/A
- Industry
- CNTY Hotels/Resorts
- GANX Biotechnology: Pharmaceutical Preparations
- Sector
- CNTY Consumer Discretionary
- GANX Health Care
- Exchange
- CNTY Nasdaq
- GANX Nasdaq
- Market Cap
- CNTY 76.3M
- GANX 69.0M
- IPO Year
- CNTY 1993
- GANX 2021
- Fundamental
- Price
- CNTY $2.58
- GANX $2.02
- Analyst Decision
- CNTY Strong Buy
- GANX Strong Buy
- Analyst Count
- CNTY 6
- GANX 6
- Target Price
- CNTY $5.00
- GANX $8.00
- AVG Volume (30 Days)
- CNTY 39.9K
- GANX 779.8K
- Earning Date
- CNTY 11-03-2025
- GANX 11-13-2025
- Dividend Yield
- CNTY N/A
- GANX N/A
- EPS Growth
- CNTY N/A
- GANX N/A
- EPS
- CNTY N/A
- GANX N/A
- Revenue
- CNTY $574,729,000.00
- GANX N/A
- Revenue This Year
- CNTY $4.95
- GANX N/A
- Revenue Next Year
- CNTY $6.15
- GANX N/A
- P/E Ratio
- CNTY N/A
- GANX N/A
- Revenue Growth
- CNTY N/A
- GANX N/A
- 52 Week Low
- CNTY $1.30
- GANX $1.41
- 52 Week High
- CNTY $5.09
- GANX $3.19
- Technical
- Relative Strength Index (RSI)
- CNTY 44.28
- GANX 58.27
- Support Level
- CNTY $2.59
- GANX $1.74
- Resistance Level
- CNTY $2.69
- GANX $2.40
- Average True Range (ATR)
- CNTY 0.09
- GANX 0.18
- MACD
- CNTY -0.01
- GANX 0.04
- Stochastic Oscillator
- CNTY 7.09
- GANX 49.72
About CNTY Century Casinos Inc.
Century Casinos Inc is a casino entertainment company that develops and operates gaming establishments as well as related lodging, restaurants, horse racing (including off-track betting), and entertainment facilities in North America. The company has three reportable segments based on the geographical locations in which its casinos operate; United States; Century Casino & Hotel-Central City, and Century Casino & Hotel-Cripple Creek in Colorado, Mountaineer Casino, Racetrack & Resort in West Virginia, and Century Casino Caruthersville, and Century Casino Cape Girardeau in Missouri, Canada; Century Casino & Hotel, Century Casino St. Albert, Century Mile Racetrack in Edmonton and Casino Century Downs Racetrack and Casino in Calgary, and Poland; Casinos Poland.
About GANX Gain Therapeutics Inc.
Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. Geographically, the company operates in Switzerland, Spain, the United States, and Australia.